BioSpace News Archive

FDA

Kashiv Biosciences Achieves Second U.S. Biosimilar Approval with FYLNETRA® (pegfilgrastim-pbbk)

Kashiv Biosciences, LLC (“Kashiv” or the “Company”) is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved its Biologics License Application (“BLA”) for pegfilgrastim-pbbk, a biosimilar referencing Neulasta®.

May 31, 2022
·
4 min read
Veterinary Endoscopes Market Size to Hit US$ 415.2 Mn by 2030

The global veterinary endoscopes market size is expected to be worth around US$ 415.2 million by 2030 and is anticipated to grow at a CAGR of 7.6% over forecast period 2021 to 2030.

May 31, 2022
·
4 min read
Liver Cancer Diagnostics Market Size to Worth US$ 20.4 Bn by 2030

According to Vision Research Reports, the liver cancer diagnostics market size is expected to be worth around US$ 20.4 billion by 2030 from valued at US$ 10.7 billion in 2020 and is anticipated to grow at a CAGR of 8.5% from 2021 to 2030.

May 31, 2022
·
3 min read
Biopsy Guidance System Market Size to Worth US$ 1,883.5 Mn by 2030

According to Vision Research Reports, the global biopsy guidance system market size is expected to be worth around US$ 1,883.5 Million by 2030 and is predicted to grow at a CAGR of 5.9% during forecast period 2021 to 2030.

May 31, 2022
·
7 min read
Healthcare ERP Market Size to Worth Around US$ 15.3 Bn by 2030

According to Vision Research Reports, the global Healthcare ERP Market size is expected to worth around US$ 15.3 billion by 2030 and is projected to grow at a CAGR of 8.6% during forecast period 2021 to 2030.

May 31, 2022
·
6 min read
Circulating Tumor Cells Market Size to Surpass US$ 20.3 Bn by 2030

The global circulating tumor cells market size is expected to worth around US$ 20.3 billion by 2030 from valued at US$ 10.4 billion in 2020 and is anticipated to grow at a CAGR of 15.7% from 2021 to 2030.

May 31, 2022
·
6 min read
Healthcare CRM Market Size to Worth Around US$ 27.8 Bn by 2030

According to Vision Research Reports, the Healthcare CRM market size is expected to be worth around US$ 27.8 billion by 2030 from valued at US$ 17.7 billion in 2020 and growing at a CAGR of 10.1% from 2022 to 2030.

May 31, 2022
·
5 min read
Non-invasive Aesthetic Treatment Market Size to Worth US$ 150 BN by 2030

According to Vision Research Reports, the Non-invasive Aesthetic Treatment market size is expected to be worth around US$ 150 billion by 2030 from valued at US$ 49 billion in 2020 and growing at a CAGR of 15.7% from 2021 to 2030.

May 31, 2022
·
3 min read
Genetown

Foghorn Therapeutics Announces Upcoming Investor Conference Participation

Foghorn® Therapeutics Inc. announced management’s participation in the following investor conferences.

May 31, 2022
·
1 min read
Genetown

CinCor Pharma to Present at the Jefferies Healthcare Conference

CinCor Pharma, Inc. announced participation at the Jefferies 2022 Healthcare Conference taking place June 8 - 10 in New York, New York.

May 31, 2022
·
1 min read